Ravgen was designed to be a safe option for mothers. The innovative procedure has been approved by governing bodies. The College of American pathologists (CAP) has recognized and approved the technology. Ravgen technology has received a certificate of accreditation under the Clinical Laboratory Improvement Amendments (CLIA). The prenatal DNA paternity test only requires a safe blood draw from the mother to exclude or confirm a father with over 99% accuracy. We perform reliable DNA testing from fetal DNA present in the mother’s blood after the 8th week of pregnancy. The process and technology has been reviewed, critiqued and approved by governing bodies that verify the safety of Ravgen testing.